Cite

HARVARD Citation

    Maldonado, I. et al. (2022). Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years. Human vaccines & immunotherapeutics. 18 (5), p. . [Online]. 
  
Back to record